Yang Hongwei, Chief Physician of Breast and Thyroid Surgery at Suining Central Hospital, presented a special lecture titled, "The Effectiveness and Safety of HIFU in Treating Breast Fibroadenoma." During his presentation, he highlighted the numerous benefits of using High-Intensity Focused Ultrasound (HIFU) for treating breast fibroadenoma. The key advantages of this method include its noninvasive nature, meaning it doesn't cause any physical trauma, risk of bleeding or infection, or leave any incision scars on the skin. Another major benefit is its capability for real-time monitoring and precise, conformal ablation. Moreover, the procedure can be performed under local anesthesia, thus significantly reducing the treatment time. Importantly, HIFU enables the treatment of multiple lesions in a single session and allows for repeatable treatments, making it an especially suitable option for patients with multiple or recurrent breast fibroadenomas. Lastly, the absence of radiation and chemical damage ensures the overall safety of this treatment method.

Dr. Zhu Lin, Chief Physician at the Second Hospital of Shandong University, delivered a lecture titled, "Tumor-free Operation and Parametrial Management in Laparoscopic Surgery for Early-Stage Cervical Cancer." He explained that Laparoscopic Radical Hysterectomy (LRH) can be conducted without a uterus manipulator, provided there is a comprehensive preoperative evaluation that includes staging, imaging, and self-assessment. Dr. Lin underscored the importance of understanding the treatment principles as set out by FIGO (International Federation of Gynecology and Obstetrics) staging and NCCN (National Comprehensive Cancer Network) guidelines. He stressed the necessity for physicians to comprehend the various hysterectomy QM subtypes, their respective applications, and to carefully select cases of C1 and extensive cervical types. He encouraged physicians to gain proficiency over time but warned against overstepping their expertise level, always prioritizing the patient's interests first.

Zhang Cai, Head of the Medical Research Department at the National Engineering Research Center of Ultrasound Medicine, presented a "Comparison of Cosmetic Outcomes and Cost-Effectiveness Among Different Treatments for Breast Fibroadenoma." She concluded that compared to other treatments, HIFU treatment for breast fibroadenoma is cost-effective and offers higher utility. It can treat more lesions in a single session, achieve a higher rate of complete treatment of multiple lesions, require shorter treatment time for individual lesions, and present no postoperative adverse events. According to her findings, patients who received HIFU treatment experienced improved physical and psychological conditions postoperatively.